INDIANAPOLIS — Carl H. June, M.D., an internationally recognized leader in the growing field of immune therapy to treat cancer, will be the Watanabe Prize winner and speaker Friday at the annual meeting of the Indiana Clinical and Translational Sciences Institute.
Dr. June, Richard W. Vague professor in immunotherapy and director of the Center for Cellular Immunotherapies in the Perelman School of Medicine at the University of Pennsylvania, has led the development and testing of novel forms of immunotherapy in cancer and chronic infections, making groundbreaking contributions in determining mechanisms by which the body’s immune system can be activated to attack such diseases.
The Indiana CTSI will host its seventh annual meeting and Watanabe Prize Lecture on the campus of Indiana University — Purdue University Indianapolis.
The August M. Watanabe Prize in Translational Research, presented by the Indiana CTSI and the Indiana University School of Medicine, recognizes a member of the scientific or medical community who has achieved outstanding accomplishments in translational research. As the recipient, Dr. June will spend several days in Indiana sharing his knowledge with audiences at the Indiana University School of Medicine and partner institutions. The Indiana CTSI annual meeting will also highlight two outstanding young investigators named Watanabe Translational Scholars. They will present a brief overview of their research during the event and will be mentored by Dr. June over the next two years.
In addition to the keynote address, Hal Broxmeyer, Ph.D., and Sophie Paczesny, M.D., Ph.D., of the IU School of Medicine, Michael Kalos Ph.D., from Lilly Research Laboratories, and Rob Lyles and Erik Woods from Cook Regentec will share their latest findings in immune and cell based therapies.
The Indiana CTSI will also host a poster session as part of the 2015 annual meeting. There will be best poster prizes awarded for trainees and investigator categories. Additionally, top posters from this session will be selected and highlighted during a Research Day at Lilly Corporate Center.
The meeting will take place at Hine Hall Auditorium, 850 W. Michigan St., from 7:30 a.m. – 3 p.m. Registration, and the meeting agenda, are available at the meeting registration website.
About the Indiana CTSI: Established in 2008, The Indiana Clinical and Translational Sciences Institute, directed by Anantha Shekhar, M.D., Ph.D., is a statewide collaboration of Indiana University, Purdue University and the University of Notre Dame along with many public and private corporate partnerships to facilitate the translation of scientific discoveries in the lab into new patient treatments in Indiana and beyond. For more information, visit indianactsi.org.